Case Western Reserve University Wins $11.3M for New GI Cancer Program | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Case Western Reserve University School of Medicine has netted $11.3 million from the National Cancer Institute to start a program that will use genomics and other approaches to study and develop tools to fight gastrointestinal cancers.

The funding will establish a Specialized Program of Research Excellence (SPORE) in gastrointestinal cancers, which will focus on translational research into new ways to diagnose, treat, and prevent cancers of the colon and esophagus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.